Find your next paid study

Jasper GerritsenNCT06283927

~$10 – $1,125

Actual pay is set by the research site.

Phase 2

A Phase II Study of Induction Tucatinib and Trastuzumab With Total Neoadjuvant Therapy for Locally Advanced HER2-amplified Rectal Adenocarcinoma

The study researchers believe that a combination of the drugs trastuzumab and tucatinib, given with standard chemotherapy (capecitabine and oxaliplatin/FOLFOX)…

Adenocarcinoma of the RectumLocally Advanced Rectal AdenocarcinomaRectal Adenocarcinoma+2 more

Memorial Sloan Kettering Cancer CenterNCT05672524

~$75 – $2,000

Actual pay is set by the research site.

Phase 1

An Open-label, Phase 1a/1b, Dose Escalation and Dose Expansion Study Investigating the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of PHST001 in Adult Patients With Advanced Relapsed and/or Refractory Solid Tumors

This is a multi-center, first-in-human (FIH), open-label, Phase 1a/1b dose escalation and dose expansion study to assess the safety, PK, pharmacodynamics, and …

Advanced Solid TumorsOvarian CancerEndometrial Cancer+6 more

Pheast TherapeuticsNCT06840886

~$150 – $4,200

Actual pay is set by the research site.

Neonatal Respiratory Distress Related ConditionsMeconiumPerinatal Morbidity+10 more

The PEARL Trial: A Randomized Trial of Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Thick Meconium Exposure

Thick meconium in the amniotic fluid occurs in about one out of seven pregnancies and increases the chance that a newborn may have breathing problems after bir…

Medical College of WisconsinNCT07274527

Actual pay is set by the research site.

Phase 2

A Phase 2 Study of Intratumoral Administration of L19IL2/L19TNF in Locally Advanced Cutaneous Squamous Cell Carcinoma Patients Progressing on or Intolerant to Systemic Treatment

Open-label, single-arm, multicenter study in patients with locally advanced, histologically confirmed Cutaneous Squamous Cell Carcinoma (LacSCC) amenable to in…

Locally Advanced Cutaneous Squamous Cell Carcinoma

Philogen S.p.A.NCT07228442

~$75 – $3,000

Actual pay is set by the research site.

Advanced Malignant Solid NeoplasmMalignant Brain NeoplasmRecurrent Advanced Malignant Solid Neoplasm

Empowerment Through Preparedness: Improving Advance Care Planning (ACP) in Adolescents and Young Adults (AYAs) With Advanced Solid Malignancies and High-Grade Brain Tumors

This clinical trial studies whether educational tools work to improve early advance care planning (ACP) in adolescents and young adults (AYAs) with solid tumor…

Actual pay is set by the research site.

Mayo ClinicNCT07174661

Myelopathy, CompressiveRadiculopathy, CervicalC5 Palsy

A Randomized, Prospective Study Determining the Impact of Prophylactic Bilateral Foraminotomy During Cervical Decompression on C5 Palsy

C5 palsy (C5P) is a well-known, although rare complication of cervical spine decompression surgery. In severe forms, C5P causes debilitating upper extremity we…

The Cleveland ClinicNCT03023696

Actual pay is set by the research site.

Critical IllnessPalliative CareOlder Adults+2 more

Improving Needs Among Older Adults: the ICUconnect 2 Primary Palliative Care RCT

Millions of older adults receive care in intensive care units (ICUs) annually. However, the quality and accessibility of ICU-based palliative care is highly va…

Duke UniversityNCT06588556

Actual pay is set by the research site.

Adenocarcinoma of the ColonAdenocarcinoma of the Rectum

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

This trial examines colorectal cancer incidence in participants with 1 to 2 non-advanced adenomas randomized to surveillance colonoscopy at 10 years compared t…

Advanced Solid TumorMelanomaHead and Neck Cancer+11 more

~$10 – $1,125

Actual pay is set by the research site.

NRG OncologyNCT05080673

Phase 2

HERTHENA-PanTumor01 (U31402-277): A Phase 2, Multicenter, Multicohort, Open-Label, Proof of Concept Study of Patritumab Deruxtecan (HER3-DXd; U3-1402) in Subjects With Locally Advanced or Metastatic Solid Tumors

This is a proof-of-concept study designed to investigate HER3-DXd monotherapy in locally advanced unresectable or metastatic solid tumors. The study is enrolli…

Daiichi SankyoNCT06172478

~$75 – $3,000

Actual pay is set by the research site.

Phase 1

A Phase I/IIa Randomized Clinical Trial to Evaluate the Efficacy of EGFR-targeted, PNU-159682-packaged Nanocells & Glycolipid-Packaged Nanocells in Combination With Gemcitabine & Nab-paclitaxel in Metastatic Pancreatic Ductal Adenocarcinoma

The purpose of this study is to evaluate the safety and tolerability and overall survival (OS) of E-EDV-D682/GC in combination with gemcitabine and nab-paclita…

Pancreatic Cancer, MetastaticPDAC - Pancreatic Ductal Adenocarcinoma

Engeneic Pty LimitedNCT07049055

~$150 – $4,200

Actual pay is set by the research site.

Phase 1

A First-in-human, Phase 1/2, Open-label, Multi-center, Dose-escalation and Dose-expansion Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of the ATR Inhibitor IMP9064 Monotherapy and in Combination With PARP Inhibitor Senaparib in Patients With Advanced Solid Tumors

This is a Phase 1/2, multicenter, open-label study to evaluate the safety and efficacy of IMP9064 as monotherapy or in combination with PARP inhibitor Senapari…

Solid TumorAdvanced Solid Tumor